Clinical Research Directory

Inclusion Criteria: * Participants aged 45-65 years, with a confirmed diagnosis of metabolic dysfunction-associated fatty liver disease (MAFLD), * a body mass index (BMI) ≥25 kg/m², * HbA1c ≥5.7%, * elevated serum cytokeratin-18 (CK-18) Exclusion Criteria: * Participants who had initiated or changed hypoglycemic, lipid-lowering, antihypertensive, hepatoprotective, corticosteroid, or weight-loss medications within the three months preceding enrollment were excluded, * Pregnant or lactating women, individuals with known allergies or hypersensitivity to flaxseed, olive oil, or other herbal products used in the intervention, * participants with severe hepatic, renal, cardiovascular, or other systemic diseases that could interfere with the study outcomes